Overview

Rapip Study: Clinical Trial on Remifentanyl for Analgesia and Sedation of Ventilated Neonates and Infants

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
It shall be investigated whether ventilated neonates and infants with a remifentanyl based analgesia and sedation can be extubated faster after discontinuation of the opioid infusion compared to neonates and infants with a fentanyl based analgesia and sedation.
Phase:
Phase 3
Details
Lead Sponsor:
University of Cologne
Collaborator:
GlaxoSmithKline
Treatments:
Fentanyl
Remifentanil